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P L A N T  S C I E N C E S
Neurotoxic peptides from the venom of the giant 
Australian stinging tree
Edward K. Gilding1*, Sina Jami1*, Jennifer R. Deuis1*, Mathilde R. Israel1,2, Peta J. Harvey1,  
Aaron G. Poth1, Fabian B. H. Rehm1, Jennifer L. Stow1, Samuel D. Robinson1, Kuok Yap1,  
Darren L. Brown1, Brett R. Hamilton3, David Andersson2, David J. Craik1,  
Irina Vetter1,4†, Thomas Durek1†
Stinging trees from Australasia produce remarkably persistent and painful stings upon contact of their stiff 
epidermal hairs, called trichomes, with mammalian skin. Dendrocnide-induced acute pain typically lasts for several 
hours, and intermittent painful flares can persist for days and weeks. Pharmacological activity has been attributed 
to small-molecule neurotransmitters and inflammatory mediators, but these compounds alone cannot explain 
the observed sensory effects. We show here that the venoms of Australian Dendrocnide species contain heretofore 
unknown pain-inducing peptides that potently activate mouse sensory neurons and delay inactivation of 
voltage-gated sodium channels. These neurotoxins localize specifically to the stinging hairs and are miniproteins of 
4 kDa, whose 3D structure is stabilized in an inhibitory cystine knot motif, a characteristic shared with neurotoxins 
found in spider and cone snail venoms. Our results provide an intriguing example of inter-kingdom convergent 
evolution of animal and plant venoms with shared modes of delivery, molecular structure, and pharmacology.
INTRODUCTION
Australia notoriously harbors some of the world’s most venomous 
animals, but although less well known, its venomous flora is equally 
remarkable. The giant Australian stinging tree Dendrocnide excelsa 
reigns superlative in size, with some specimens growing to 35 m tall 
along the slopes and gullies of eastern Australian rainforests (fig. S1). 
However, these members of the Urticaceae family are far more 
than oversized nettles. Of the six Dendrocnide species native to the 
subtropical and tropical forests of Eastern Australia, D. excelsa (lit. 
tall stinging tree) and D. moroides (lit. mulberry-like stinging tree) 
are particularly notorious for producing excruciatingly painful 
stings, which—unlike those of their European and North American 
relatives—can cause symptoms that last for days or weeks in 
extreme cases (1, 2). In the state of Queensland, it is not uncommon 
to find warning signs along forest tracks, alerting unwary visitors to 
the presence of Dendrocnide species and the potency of their sting 
(Fig. 1A). This signage is justified given that D. moroides has been 
implicated in hospitalization of two individuals requiring intensive 
care for 36 hours who suffered from acute pain that reportedly did 
not respond to morphine and ongoing symptoms lasting months 
(3). This long-lasting pain is also typical of other Dendrocnide 
species stings, with episodic pain typically subsiding over several 
weeks, although paresthesiae may persist longer (4).
However, although Dendrocnide stings are common and many 
Australians—including the authors—vividly recall their personal 
experiences with stinging trees, most of the cases do not require 
hospitalization, and accordingly, there is little literature systematically 
evaluating the clinical presentation. Generally, severe pain is the 
predominant symptom, although neuromuscular symptoms and 
respiratory distress have also been reported (2, 3). In addition to 
simple or opioid analgesics, the severe pain is anecdotally treated 
with dilute hydrochloric acid—presumed to denature venom com-
ponents—or wax strips, based on the likely erroneous assumption 
that persistent symptoms are caused mechanically through stinging 
hairs remaining embedded in the skin.
Like other stinging nettles of the Urticaceae family, the leaves 
and stems of D. excelsa and D. moroides are covered with needle- 
shaped trichomes resembling a covering of deceptively benign felt-
like hairs (Fig. 1, B and C). These silicified secretory structures act 
as hypodermic needles (5) that, upon contact with skin, inject specific 
pharmacological mediators contained within the trichome fluid, 
leading to activation of nerve terminals innervating the skin (6, 7).
Several small-molecule compounds have been proposed to account 
for the observed physiological effects of common Urtica stings. 
These irritation-inducing molecules include histamine, acetylcholine, 
5-hydroxytryptamine (8–10), as well as formic acid and other low–
molecular weight organic acids (11). Although these compounds may 
explain some immediate discomfort associated with nettle stings, 
intradermal injection of dialyzed stinging hair extract containing 
none of these small molecules in the volar forearm of humans was 
entirely sufficient to reproduce the symptoms of a Dendrocnide sting, 
and addition of histamine, acetylcholine, and 5-hydroxytryptamine 
at amounts measured from trichomes neither changed the nature of 
the pain caused by Dendrocnide extract nor caused substantial 
long-lasting pain if injected alone (2). The inability to replicate the 
remarkable severity and extended duration of the pain with the 
small-molecule mixture suggests the presence of unidentified 
neurotoxins and inspired our investigation into the pharmacological 
basis of pain induced by the giant Australian stinging tree.
RESULTS
Pain-inducing compounds from Dendrocnide venom
The stings are mediated by trichomes that measure up to about 
7 mm in length in D. excelsa and D. moroides (Fig. 1, B and C). It is 
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the tip that effects envenomation by breakage and leakage of trichome 
contents. Contact with the trichomes during an accidental sting of a 
healthy 41-year-old individual resulted in an almost immediate 
sharp stinging sensation that was accompanied by local piloerection, 
wheals, and a slowly developing axon reflex flare persisting for several 
hours (Fig. 1, D to G). These cutaneous reactions were accompanied 
by painful sensations of increasing intensity, including deep aching 
and burning pain that can radiate to the ipsilateral axilla, and that is 
frequently interspersed by intermittent sharp stabbing pains. In 
addition to pain, crawling or tingling sensations and other par-
aesthesiae are also common symptoms in the experience of the 
authors. Although painful, treatment of the sting was not required.
To better understand the molecular basis for the observed phar-
macological effects, we prepared stinging hair extracts from D. excelsa, 
fractionated the compound mixture via high-performance liquid 
chromatography (HPLC), and assessed the sensory effects of the 
resulting fractions in an in vivo model. A single, late-eluting peak 
(Fig. 1H) evoked nocifensive behaviors and was further character-
ized by mass spectrometry (MS): Matrix-assisted laser desorption/
ionization MS (MALDI-MS) revealed several molecules with a mass 
of ~4 kDa, and reduction and alkylation coupled with tryptic 
digests further confirmed the presence of miniproteins containing 
three disulfide bonds (fig. S2A).
A short sequence tag, obtained via tandem MS, was used to 
interrogate a transcriptome assembled from RNA sequencing data 
of D. excelsa (fig. S2B). Further transcriptome analysis of D. moroides 
and complementary DNA (cDNA) cloning revealed a family of 
disulfide-rich peptides of 36 amino acid residues (Fig. 2A). The 
mature peptide sequences do not show any similarity to known se-
quences, although their cysteine pattern is similar to inhibitory cys-
tine knot (ICK) peptides found in albumin-derived plant peptides 
and conotoxin Gm9a (Fig. 2 and fig. S2C) (12). The name chosen for 
these molecules from Dendrocnide trichomes, “gympietides,” is de-
rived from the name in the Gubbi Gubbi language for the stinging 
Fig. 1. Stinging nettles of the genus Dendrocnide produce potent neurotoxins. (A) Sign at a North Queensland National Park advising caution around stinging trees. 
(B) D. excelsa petioles are covered in stinging hairs. (C) Scanning electron micrograph of trichome structure on the leaf of D. moroides. (D to G) Cutaneous reaction resulting 
from an accidental sting with D. moroides documented with an iPhone XR and NEC G120W2 thermal imager, illustrating almost immediate local piloerection [arrowheads 
in (D)], development of wheals where stinging hairs penetrate the skin [arrows in (E)], as well as a long-lasting axon reflex erythema [arrows in (F) and (G)] and associated 
local increase in skin temperature (°C). (H) HPLC chromatogram of trichome extract from D. excelsa. Diamonds indicate nocifensive responses elicited by intraplantar 
administration of individual fractions in vivo in C57BL6/J mice, with a single late-eluting peak identified as the main pain-causing fraction. Photo credits: (A and D to G): 
Irina Vetter, The University of Queensland; (B): Thomas Durek, The University of Queensland; (C): Darren Brown, The University of Queensland.
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trees (gympie-gympie) (13). To further delineate their nomenclature, 
peptides of this class from similar precursors are named with the 
prefix ExTx (Excelsatoxin, of D. excelsa) and MoTx (Moroidotoxin, 
of D. moroides). To unequivocally demonstrate the anticipated phar-
macological activity of these molecules, we chemically synthesized 
ExTxA and MoTxA (fig. S3, A and B) and confirmed their structural 
identity with crude trichome extract– derived toxins via multiple re-
action monitoring (MRM) MS (fig. S3C). Quantitative MRM analysis 
indicated a substantially higher abundance of ExTxA in trichome 
extracts compared to extracts prepared from the same aerial parts of 
the same plant but with the trichomes removed, further supporting 
a stinging hair–specific defense role of these molecules (fig. S4). 
Consistent with the putative neurotoxic action of the gympietides, 
sections of D. excelsa petioles examined with MALDI imaging re-
vealed the presence of masses matching ExTxA (3881.5 Da; Fig. 2D) 
particularly in areas where stinging trichomes and trichome support 
cells are present.
The three-dimensional (3D) structure of synthetic ExTxA was 
determined by simulated annealing using nuclear magnetic reso-
nance (NMR)–derived nuclear Overhauser effect (NOE) distance 
and angular restraints and deuterium exchange kinetics (fig. S5). 
The models confirm the anticipated ICK structure of ExTxA and, 
despite limited sequence similarity to other ICK peptides, further 
highlight the structural plasticity of this widespread peptide scaffold 
(Fig. 2B and fig. S5E).
Gympietide pharmacology
When injected into the hind paw of mice at low doses (0.1 to 1.2 pmol/ 
40 l), synthetic ExTxA and MoTxA faithfully and dose-dependently 
recapitulated the neurotoxic effects of Dendrocnide stings, causing 
nocifensive behavior (licking or biting and shaking or lifting of the 
affected paw) lasting for approximately 1 hour [nocifensive behaviors/ 
1 hour: saline, 13 ± 4 (n = 3); ExTxA 1 nM, 8 ± 2 (n = 4); ExTxA 
3 nM, 100 ± 17 (n = 6); ExTxA 10 nM, 173 ± 18 (n = 5); ExTxA 30 nM, 
258 ± 30 (n = 6); MoTxA 10 nM, 421 ± 18 (n = 5)]. This behavior 
was accompanied by an axon reflex flare that was sustained for 
several hours after injection (ipsilateral paw temperature, 1 hour: 
32.5 ± 0.3°C; contralateral paw temperature, 1 hour: 25.2 ± 0.2°C; 
F6,28 = 17.25, P < 0.0001), resembling the reaction seen in humans 
(Figs. 1, F and G, and 3, A and B). We next assessed the effect of 
ExTxA on sensory nerve excitability using the murine skin–saphenous 
nerve preparation. Application of ExTxA (100 nM) to the receptive 
fields of mechanosensitive A- and C-fibers caused spontaneous 
action potential (AP) firing in most of the fibers, often inducing 
long-lasting high-frequency bursts (C-fiber APs/5 min: buffer, 
0.8 ± 0.8; ExTxA, 191 ± 31; P = 0.0313; A-fiber APs/5 min: buffer, 
0 ± 0; ExTxA, 251 ± 93, P = 0.0197) (Fig. 3, C to E), confirming direct 
activation of primary sensory neurons.
To gain insight into the pharmacological activity of ExTxA, we 
next assessed responses of dorsal root ganglion (DRG) neurons to 
ExTxA and MoTxA using fluorescence Ca2+ microscopy (Fig. 3, F to J, 
and fig. S6). Consistent with its neurotoxic effects, ExTxA caused 
Ca2+ influx in neurons, but not nonexcitable cells (fig. S6), with 68% 
of neurons (n = 523) (MoTxA; 73 ± 5%, n = 288) responding at a 
concentration of 10 nM (F/F 2.080 ± 0.056) (Fig. 3, G to J, and fig. S6).
The excitatory effects of ExTxA were apparent in neurons of all 
sizes, including capsaicin-responsive nociceptors, and the proportion 
of neurons responding was significantly (F = 49.91, P = 0.0008) 
reduced to 26% (n = 146) in the presence of tetrodotoxin (TTX; 
1 M), suggesting activity at voltage-gated Na+ channels (Fig. 3, G to J). 
We therefore assessed the effect of ExTxA (50 nM) on total voltage- 
gated Na+ current using patch-clamp electrophysiology in DRG 
neurons and observed a notable delay in fast inactivation that resulted 
in a sustained current (I40ms/Ipeak: control, 0.04 ± 0.02; ExTxA, 
0.31 ± 0.04; df = 7, P < 0.0001; Fig. 4, A and B). This sustained 
current was abolished by replacement of external Na+ ions with choline 
and was inhibited by TTX (1 M), confirming that ExTxA directly 
acts at voltage-gated sodium (NaV) channels (Fig. 4C). In more 
detailed mechanism of action studies, we tested the gympietides 
using TE671 cells endogenously expressing the neuronal NaV1.7, as 
confirmed by CRISPR knockdown experiments demonstrating 
significant decrease in current size (fig. S6, A and B). In NaV1.7- 
expressing TE671 cells, ExTxA (1 M) caused a significant hyper-
polarizing shift in the voltage dependence of activation ( −7.2 mV, 
df = 4, P = 0.0014), with no significant effect on the voltage depen-
dence of steady-state fast inactivation (Fig. 4D). Similarly, MoTxA 
(10 nM) shifted the voltage dependence of activation ( −7.2 mV, 
df = 6, P = 0.036) but not the voltage dependence of steady-state fast 
Fig. 2. Gympietides define a previously unidentified family of ICK peptides from stinging nettles. (A) Sequence alignment of 4-kDa miniproteins from D. excelsa (ExTxA-C) 
and D. moroides (MoTxA), as well as the structurally related ICK peptides leginsulin (Glycine max), PA1b (Pisum sativum), and conotoxin Gm9a (Conus gloriamaris). (B) NMR 
structure model of ExTxA. (C) Stinging trichomes of D. excelsa and (D) MALDI-IMS heat map distribution of m/z (mass/charge ratio) 3881.5 Da indicating trichome-specific 
expression of ExTxA. Photo credits (C and D): Thomas Durek, The University of Queensland.
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inactivation, and lower concentrations of ExTxA (100 nM) also 
elicited qualitatively similar shifts in the voltage dependence of 
activation ( −5.6 mV, df = 6, P = 0.013) but not the voltage depen-
dence of steady-state fast inactivation (fig. S6). Both ExTxA and 
MoTxA potently delayed NaV inactivation in a concentration- 
dependent manner, with median effective concentrations (EC50s) of 
58 and 4 nM (pEC50 ExTxA, 7.24 ± 0.12; pEC50 MoTxA, 8.39 ± 0.18), 
respectively (Fig. 4E). Despite structural similarity to the gympietides, 
the most closely related pea-derived peptide PA1b (1 M) had 
no effect on voltage-gated sodium currents (Fig. 4E). The effects of 
ExTxA on Na+ currents were irreversible, with no apparent reduction 
in activity even after repeated wash steps over 30 min (Fig. 4F). 
Consistent with these pharmacological effects on NaV channels, 
both TTX as well as the NaV1.7-selective inhibitor Pn3a (14, 15) 
Fig. 3. Synthetic ExTxA and MoTxA activate sensory neurons in vivo and in vitro. (A) Intraplantar injection of synthetic ExTxA and MoTxA caused dose-dependent 
nocifensive behaviors in C57BL/6 mice as well as (B) local hyperemia resulting in a significant increase in skin temperature. Inset: Thermal image illustrating the ExTxA- 
induced axon reflex vasodilation. *P < 0.05 by repeated-measures two-way ANOVA; n = 3 to 6. (C) Exposure of the cutaneous receptive fields of sensory neurons to syn-
thetic ExTxA caused spontaneous AP firing in A-fibers (black circles) and C-fibers (open circles). (D and E) Representative recordings from the murine skin–saphenous 
nerve preparation illustrating ExTxA-induced activity in A-fibers (D) and C-fibers (E). Open circles, APs plotted as instantaneous frequency. (F to H) ExTxA (10 nM) induces 
Ca2+ influx in DRG neurons (white arrows), including capsaicin-sensitive nociceptors, but not nonexcitable cells (red arrowheads). (F) Pseudocolor image illustrating 
Ca2+ responses in DRG neurons (scale bar, 100 m), and (G) corresponding traces from all neurons of one representative experiment. (H) Total percentage of neuronal 
cells (±1 M TTX) and non-neuronal cells responding to ExTxA (10 nM). (I) Distribution of ExTxA-responding and nonresponding DRG neurons by cell size and (J) overlap 
with capsaicin-sensitive nociceptors. Data are presented as means ± SEM; *P < 0.05.
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decreased in vivo nocifensive behaviors elicited by ExTxA (Fig. 4G), 
suggesting that populations of neurons activated by ExTxA almost 
certainly include classical nociceptors defined by expression of NaV1.7.
DISCUSSION
The intense pain sensations and prolonged axon reflex flare ob-
served after envenomation by Dendrocnide species are consistent 
with the potent activity of the gympietides at NaV channels, leading 
to activation of cutaneous neurons and neurotransmitter-mediated 
local vasodilation (16). Notably, although doses of the gympietides 
delivered by stinging hairs are difficult to estimate, our quantifica-
tion of ExTxA content using MS places the approximate amount 
present in trichomes (2.5 to 5.0 pmol per trichome) close to doses 
eliciting symptoms of synthetic material in vivo (0.1 to 1.2 pmol 
per animal; Fig. 3, A and B). The comparatively smaller bicyclic 
peptide moroidin, which has been isolated from the leaves of 
D. moroides as well as Celosia argentea previously (17), consists of 
eight amino acid residues and has been thought to contribute to 
painful symptoms. However, moroidin, which is present at approx-
imately 0.002% (w/w) in crude D. moroides leaf extract, only elicited 
a modest pain reaction after local injection of 10 g of purified 
material, despite 1 g of crude leaf extract eliciting a severe response 
(18, 19). Our initial attempts to isolate moroidin to pharmacologi-
cally characterize the effects of this octapeptide on cultured sensory 
neurons failed, and we were unable to detect any of this compound 
in the trichomes or leaves of D. excelsa.
The extended duration of the nociceptive responses to Dendrocnide 
stings was replicated by injection of synthetic ExTxA in vivo and can 
be explained by the irreversible action of ExTxA on NaV channels 
(Fig. 4), providing a pharmacological basis for the unique proper-
ties of the Australian stinging trees. This activity is particularly 
remarkable given that the primary structure of the gympietides is 
unique, with very limited similarity to known sequences. In con-
trast, the tertiary structure and function of these peptides are remi-
niscent of -therapotoxins, -hexatoxins, and -conotoxins from 
arachnid and cone snail venoms, respectively (fig. S5E). Hence, 
gympietides are the first plant-derived knottins with activity at NaV 
channels reported to date, thus making them prototypic representa-
tives of this previously unknown class of plant peptides. Their struc-
tural similarity and a delivery mode identifiable as envenomation 
exemplify cross- kingdom convergence of venoms (20). While the 
Australian stinging trees have evolved an effective defense against 
humans, and other mammals based on anecdotal reports, it remains 
unclear currently whether this defensive activity has contributed to 
the evolution of the gympietides or whether there are species differ-
ences in the pharmacological activity of this peptide class that may 
confer other benefits to these plants.
Although detailed structure-activity relationships remain to be 
explored, MoTxA was more potent than ExTxA, providing a possi-
ble explanation for anecdotal reports that stings from D. moroides 
are more severe than those from D. excelsa (21). While we cannot 
currently exclude activity at other neuronal targets, including other 
NaV subtypes, modulation of NaV1.7 by the gympietides sufficiently 
explains the observed in vitro and in vivo effects and suggests that 
NaV channel blockers may provide pain relief to stinging tree 
victims clinically. The gympietides affected both channel inactivation 
and V1/2 of activation, both of which may contribute to enhanced 
neuronal excitability. Notably, at higher ExTxA concentrations, there 
was also an increase in the fraction of noninactivated channels, 
despite the V1/2 of inactivation being unaffected by both ExTxA and 
MoTxA at all concentrations tested.
Fig. 4. ExTxA delays fast inactivation of voltage-gated sodium channels in sensory neurons. (A and B) ExTxA (50 nM) delays fast inactivation of voltage-gated Na+ 
current in DRG neurons. (A) Representative Na+ current trace and (B) total sustained current (40 ms from peak current), normalized to peak, from DRG neurons (n = 8). 
(C) Effect of ExTxA on sustained current is reversed by removal of external Na+ and addition of TTX (1 M) (n = 5). (D) Effect of ExTxA (green symbols) on the conductance-voltage 
(GV) curve of Na+ current compared to control (white symbols). Circles, channel activation; squares, steady-state inactivation (n = 3). (E) Concentration-dependent effects 
of ExTxA, MoTxA, and PA1b on Na+ current inactivation (n = 4 to 7 cells). (F) Effect of ExTxA (1 M) on sustained current is not reversible with repeated wash steps. Black 
arrow, peptide addition; gray arrows, washout steps (n = 4; 35 min). (G) Co-administration of TTX (1 M) or the NaV1.7-selective inhibitor Pn3a (1 M) with ExTxA by the 
intraplantar route significantly decreases in vivo nocifensive responses. n = 5 per group. Data are presented as means ± SEM; *P < 0.05.
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Altering the activation threshold, combined with effects upon 
inactivation, likely leads to nociceptor activation and the sensation 
of pain, akin to biophysical changes observed in painful conditions 
associated with NaV1.7 gain-of-function mutations such as inherited 
erythromelalgia (IEM) and paroxysmal extreme pain disorder 
(PEPD), respectively (14). As the gympietides bear little similarity 
to any other known NaV modulators and display unusual effects 
particularly on NaV inactivation, it is difficult to predict possible binding 
sites at this point. However, based on activity of animal venom– 
derived toxins and the biophysics of NaV gating, the extracellular loops 
of the domain IV voltage sensor could be a possible binding site.
In summary, we show here that the active pain-causing principle in the 
stinging hairs of Australasian stinging trees D. excelsa and D. moroides 
is a family of ultrastable miniproteins that activate nociceptors by 
modulating inactivation of voltage-gated sodium channels expressed 
on sensory neurons. The 3D structure of these gympietides is reminiscent 
of animal venom toxins targeting the same receptors, thus repre-
senting a remarkable case of inter-kingdom convergent evolution of 
animal and plant “venoms.” Our work clarifies the molecular basis 
for the pain caused by these plants while enabling structure-activity 
and convergent evolution studies to define how ancestrally distinct 
peptides in venoms may elicit the same response at pain receptors.
MATERIALS AND METHODS
Plant material
D. excelsa was collected near Mount Lindesay in southeast Queensland 
close to the New South Wales border (28°20.194′S, 152°40.403′E). 
D. moroides was collected near Atherton, far-north Queensland 
(17°10.608′S, 145°39.610′E and 17°19.889′S, 145°30.025′E). All plants 
were situated in disturbed nature strips alongside roads. Seeds of 
D. moroides were collected and sown in Jiffy peat pots and maintained 
at 28°C 16-hour/8-hour light/dark cycles under cool white fluorescent 
tubes. Upon attaining a size that could no longer be accommodated 
in the laboratory, seedlings were maintained at a mean temperature 
of 28°C in glasshouse conditions in a peat/sand soil and regular 
fertilization with a balanced fertilizer preparation.
Sample preparation for proteomics
Trichomes were isolated from expanding leaves still undergoing 
development by freezing petioles in liquid nitrogen and shaving off 
the trichomes with a scalpel. This procedure yields the silicified 
stinging hair attached to its multicellular base. Trichomes from 
several plants were combined, suspended in 50% acetonitrile (ACN)/
H2O, 0.1% trifluoroacetic acid (TFA) (~20 to 50 mg of trichomes/ml), 
and processed in a bead mill (SPEX SamplePrep, Metuchen, NJ, 
USA; Geno/Grinder, 2 × 2 min at 1200 rpm). The extract was 
cleared by centrifugation (10,000g, 5 min), and the supernatant was 
removed and lyophilized. Fractionation of the extract was achieved 
by dissolving 15 mg of lyophilized crude trichome extract in 50% 
ACN/H2O, 0.1% TFA and separating the mixture on a C18 Luna RP 
HPLC column (10 × 250 mm) with a linear gradient of 10 to 80% B 
(90% ACN/H2O, 0.08% TFA) in buffer A (0.1% TFA) over 35 min. 
Fractions were collected across the entire elution range and lyophilized.
Peptide synthesis
Gympietides were chemically synthesized by automated Fmoc 
SPPS using optimized protocols. Details for chemical synthesis 
parameters are available in the Supplementary Materials.
NMR spectroscopy and structure calculations
NMR spectroscopy was performed on Bruker Avance III 600 MHz 
or Neo 900 MHz spectrometers equipped with cryogenically cooled 
probes. Samples of synthetic ExTxA (2.4 mg) were dissolved in 
500 l of 40% (v/v) deuterated acetonitrile (ACN-D3) in water. 2D 
total correlation spectroscopy (TOCSY) (80 ms mixing time), NOE 
spectroscopy (NOESY) (200 ms mixing time), exclusive correlation 
spectroscopy (E-COSY), and natural abundance heteronuclear cor-
relation spectroscopy (15N and 13C-HSQC) were used to sequentially 
assign backbone and side-chain protons and heteroatoms. Variable 
temperature experiments were performed by recording six TOCSY 
spectra at temperatures ranging from 283 to 308 K. Slowly exchanging 
amide protons were identified by incubating ExTxA in 40% (v/v) 
ACN-D3 in D2O over 24 hours. Solvent suppression was achieved 
using excitation sculpting. Spectra were referenced to water at 
4.77 parts per million (ppm). All spectra were processed using 
TopSpin v3.6 and assigned using CcpNmr Analysis.
Distance restraints derived from the 900-MHz NOESY spectrum 
were used to calculate preliminary structures of ExTxA in CYANA, 
along with dihedral angles generated predicted by TALOS-N (22). 
Hydrogen bond pairs were added on the basis of these preliminary 
structures, amide proton temperature dependence, and slow deu-
terium exchange of proton donors. A final ensemble of structures 
was generated within central nervous system (23) using torsion angle 
dynamics and refinement and energy minimization in explicit water 
solvent. Stereochemical quality was assessed using MolProbity (24). 
Statistics describing the structural analyses are summarized in table S2.
Mass spectrometry
Details for sample preparation, tandem MS, targeted ultra-performance 
liquid chromatography (UPLC)–MS-MRM for quantification of neuro-
modulators, and MALDI imaging MS (MALDI-IMS) can be found 
in the Supplementary Materials.
Scanning electron microscopy
Plant samples for scanning electron microscopy were cut into small 
pieces and fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer 
for 2 days and then postfixed in 1% osmium tetroxide for 1 hour, 
dehydrated through ethanol, and finally dried using the Tousimis 
Autosamdri Critical Point Dryer. Samples were mounted onto alumi-
num scanning electron microscopy stubs and coated with gold for 
90 s. Images were captured using a JEOL JCM-5000 Neoscope scan-
ning electron microscope (Laboratory Scientific Engineering) at 15 kV.
RNA sequencing and transcriptome analysis
RNA was extracted from flash-frozen young shoots of D. excelsa 
and D. moroides using TRIzol reagent according to the manufacturer’s 
instructions. RNA sequencing was performed at the Australian 
Genome Research Facility (AGRF; Melbourne, Australia) on either an 
Illumina HiSeq 2500 platform (D. excelsa) or a NextSeq 6000 
platform (D. moroides), all as paired-end runs. Data were deposited 
in the National Center for Biotechnology Information (NCBI) Short 
Read Archive under BioProject accession number PRJNA592832. 
Analysis pipeline and parameters are available in the Supplementary 
Materials.
Cloning of cDNA
Total RNA was reverse-transcribed into cDNA using SuperScript III 
reverse transcriptase (Invitrogen, Carlsbad, CA, USA) using the 
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oligo(dT) priming method provided by the manufacturer. Specific 
coding sequences of interest were amplified by high-fidelity polymerase 
chain reaction (PCR) using Phusion polymerase and primers designed 
at the start and stop of putative transcripts obtained in the assem-
bled transcriptomes. Further details of primers used for cDNA 
cloning are available in the Supplementary Materials. Amplified 
products were purified from agarose gels and cloned into the vector 
pDS221 in BP Clonase (Invitrogen) reactions as per the manufac-
turer’s protocol before the purified plasmids were Sanger-sequenced 
at the AGRF. The cDNA and coding sequences for these toxins were 
deposited in NCBI GenBank as MN784116 (ExTxA), MN784117(ExTxB), 
and MN784118 (MoTxA).
Animals
Adult male and female C57BL/6J mice aged 4 to 8 weeks were 
sourced from the Animal Resource Centre (Canning Vale, Western 
Australia). Animals were housed in groups of three or four per cage 
under 12-hour light-dark cycles and had standard rodent chow and 
water ad libitum. Ethical approval for experiments involving animals 
was obtained from The University of Queensland animal ethics 
committee. All experiments were conducted in accordance with the 
International Association for the Study of Pain Guidelines for the Use 
of Animals in Research and the Australian Code of Practice for the 
Care and Use of Animals for Scientific Purposes, 8th edition (2013).
Behavioral assessment and in vivo effects
ExTxA (1 to 30 nM) or MoTxA (10 nM) was diluted in saline/0.1% 
bovine serum albumin (BSA) and administered by intraplantar 
injection to the left hind paw of male mice in a volume of 40 l under 
isoflurane (3%) anesthesia, and spontaneous pain behaviors (licks, 
bites, shakes, and lifts of the hind paw) were counted by a blinded 
investigator for 60 min after injection. To assess the effect of NaV 
inhibitors, TTX (2 M) or Pn3a (1 M) was co-administered by 
intraplantar injection with ExTxA (30 nM), and spontaneous pain 
behaviors were counted 10 min after injection. In addition, the 
surface temperature of the hind paw skin was measured following 
intraplantar injection of ExTxA (30 nM) using a NEC G120W2 
thermal camera at the time points stated. Images of cutaneous reac-
tions after an accidental sting of an author, a 41-year-old healthy 
female with unremarkable medical history, with D. moroides were 
taken using an iPhone XR with iOS13.1.3 and a NEC G120W2 ther-
mal camera at the time points stated. For statistical comparison of 
behavioral responses after intraplantar injection of ExTxA or buffer 
in C57BL/6 mice, a two-way analysis of variance (ANOVA) with time 
as a covariate using Sidak multiple comparisons test was used.
Single-fiber recordings
The saphenous nerve along with the skin of the dorsal hind paw and 
lower leg was removed from 6- to 8-week-old male and female 
C57BL/6J mice as previously described (25). The skin was placed in 
an organ chamber perfused with carbogenated synthetic interstitial 
fluid containing the following: 107.8 mM NaCl, 3.5 mM KCl, 0.69 mM 
MgSO4, 26.2 mM NaHCO3, 1.67 mM NaH2PO4, 9.64 mM Na-gluconate, 
5.55 mM glucose, 7.6 mM sucrose, and 1.53 mM CaCl2 (pH 7.3). 
The proximal end of the saphenous nerve was placed in a separate 
recording chamber immersed in paraffin oil and was desheathed 
and teased apart until a single fiber recording could be obtained. 
The receptive field was identified by mechanical probing and isolated 
using a plastic ring. We recorded from both high- and low-threshold 
mechanically excitable A- and C-fibers, which were distinguished 
based on conduction velocity and AP shape. Unfortunately, due to 
the size of the preparation and overlapping conduction velocity 
distributions, A fibers can be difficult to distinguish from A fibers 
in the murine skin–nerve preparation. We therefore included all 
A-fiber types in our analysis with the exception of rapidly adapting 
fibers that are myelinated touch fibers (25). Notably, we did observe 
activation of rapidly adapting A fibers by ExTxA, consistent with 
nonselective activation of peripheral afferents particularly at high 
concentrations. Spontaneous APs were recorded 5 min before and 
5 min after addition of ExTxA (100 nM). Data were recorded and 
analyzed using DAPSYS version 8. For statistical comparison of 
ExTxA-evoked AP firing, a two-tailed paired t test was used.
Cell culture
For Ca2+ imaging experiments, DRG neurons were isolated from 
4- to 8-week-old male C57BL/6J mice as previously described 
(26, 27). DRG neurons were dissociated and plated in 96-well 
poly-d-lysine–coated culture plates grown in Dulbecco’s modified 
Eagle’s medium supplemented with 10% fetal bovine serum (FBS) 
and penicillin/streptomycin. Isolated neurons were incubated for 
24 hours at 37°C with 5% CO2. For manual patch clamp experiments, 
DRG neurons were isolated from male and female C57BL/6J mice 
and placed in 2.5% collagenase type IV (Worthington, NJ, USA) for 
3 hours (37°C, 5% CO2). To further digest, ganglia were incubated 
with 2.5% trypsin (Sigma-Aldrich, MO, USA) for 15 min. Ganglia 
were triturated with flame-polished Pasteur pipettes and spun at 
1000 rpm through a 15% (w/v) BSA gradient to remove myelin 
debris. Last, cells were plated on poly-d-lysine (PDL)/laminin- 
coated coverslips (Corning, NY, USA) with minimum essential 
medium (MEM) (Sigma-Aldrich) supplemented with 10% (v/v) FBS, 
1% (v/v) penicillin/streptomycin, nerve growth factor (50 ng/ml) 
(Promega, WI, USA), and cytosine arabinoside (10 M) and patched 
16 to 24 hours after isolation.
TE671 cells endogenously expressing NaV1.7 [ECACC (European 
Collection of Cell Cultures), Porton Down, Salisbury, United Kingdom] 
were cultured in MEM supplemented with 10% (v/v) FBS. Cells were 
grown in a humidified 5% CO2 incubator at 37°C, grown to 70 to 
80% confluence, and passaged every 3 to 4 days using TrypLE Express 
(Invitrogen).
SCN9A CRISPR knockout
Three custom pSpCas9(BB)-2A-Puro PX459 (GenScript, Nanjing, 
Jiangsu Province, China) encoding three separate guide RNAs 
(gRNAs) (gRNA_1: 5′-CCAGTCCGGTGGGTTATTCA-3′, gRNA_2: 
5′-ACTTTCATAGTATTGAACAA-3′, gRNA_3: 5′-TATGACCAT-
GAATAACCCAC-3′) that target SCN9A (gene encoding for NaV 1.7) 
were generated. Plasmids were transfected into TE671 cells using 
Lipofectamine 3000 Transfection Reagent L30000015 (Life Technolo-
gies, Mulgrave, VIC, Australia) as per the manufacturer’s protocol 
and selected by puromycin (1 g/ml) (Life Technologies, Mulgrave, 
VIC, Australia). Na+ currents in SCN9A knockdown and progenitor 
TE671 cells were tested using patch-clamp electrophysiology 
(fig. S6, A and B).
Calcium imaging
Dissociated DRG neurons were loaded with Fluo-4 AM calcium 
indicator (5 M) for 1 hour in culture medium and then washed with 
assay solution (Hanks’ balanced salt solution containing 20 mM 
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Hepes). Typically, 100 to 150 cells per well were used by examining 
fluorescence corresponding to [Ca2+]i using a Nikon Ti-E Deconvolution 
inverted microscope, in conjunction with a Lumencor Spectra LED 
light source (excitation, 485 nm; emission, 521 nm). Images were 
acquired at 1 frame per second using a 20× objective. For each 
experiment, baseline fluorescence was observed for 20 s before 
addition of assay solution containing 0.1% BSA (negative control) 
at 30 s, 10 nM ExTxA or 10 nM MoTxA at 60 s, 1 M capsaicin at 
180 s, and 30 mM KCl (positive control) at 210 s. Excitable cells 
responding to KCl or capsaicin were classified as neuronal, while 
cells that did not respond to KCl were classified as non-neuronal 
(fig. S6C). Cells were classified as responders if they had at least 
a 1.5-fold increase in fluorescence over baseline. Any cells that 
responded to the negative control were excluded from analysis. For 
statistical comparison of ExTxA-induced Ca2+ responses in cultured 
DRG neurons, a one-way ANOVA using Tukey’s multiple compar-
isons test was used.
Electrophysiology
Whole-cell patch clamp recordings were obtained at room tem-
perature (20 ± 1°C) using an Axon MultiClamp 700B amplifier 
and pClamp (version 10) software (Molecular Devices, USA). 
Voltage-clamp intracellular solution (ICS) contained 130 mM CsF, 
20 mM NaCl, 0.2 mM EGTA, 10 mM Hepes, 4 mM Mg–adenosine 
5′-triphosphate, 0.3 mM Na–guanosine 5′-triphosphate, and 10 mM 
dextrose. Extracellular solution (ECS) contained 30 mM NaCl, 
110 mM choline-Cl, 3 mM KCl, 1 mM MgCl2, CaCl2, 10 mM Hepes, 
5 mM CsCl, 20 mM TEA (tetraethylammonium)–Cl, 0.1 mM CdCl2, 
and 1 mM 4-aminopyridine (AP). ICS and ECS were adjusted to 
pH 7.2 with KOH or CsOH, and osmolarity was adjusted using 
glucose (300 to 310 mOsm and 310 to 320 mOsm, respectively). 
Pipettes were pulled from borosilicate glass (Warner, CT, USA) 
using Narishige PC-10 pipette puller on the day of experiment and 
fire-polished (Microforge MF-830, Narishige) to a resistance of 0.9 
to 2 megohms. After whole-cell configuration was achieved, DRG 
neurons were held at −80 mV for voltage-clamp experiments. Low- 
sodium external solution was used to ensure that peak current size 
was kept well below 5 nA, ensuring adequate voltage control; there-
fore, voltage error was kept below ±5 mV using >70% series re-
sistance compensation. Recordings were acquired at 20 kHz and 
filtered with a low-pass Bessel filter at 2.9 kHz. ExTxA (50 nM, 0.1% 
BSA) or ECS (0.1% BSA) was perfused onto neurons using gravity 
perfusion (5 ml/min), and pulses to −10 mV for 100 ms were used to 
quantify persistent current (average current amplitude during final 
10 ms). For statistical comparison of Na+ current in DRG neurons, 
a two-tailed paired t test was used.
Whole-cell patch-clamp experiments in TE671a cells endogenously 
expressing NaV1.7 were performed on a QPatch-16 automated electro-
physiology platform (Sophion Bioscience, Ballerup, Denmark) as 
previously described (28). The ECS contained 145 mM NaCl, 4 mM 
KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM Hepes, and 10 mM glucose 
(pH 7.4) (osmolarity, 305 mOsm). The ICS contained 140 mM CsF, 
1 mM/5 mM EGTA/CsOH, 10 mM Hepes, and 10 mM NaCl (pH 7.3) 
with CsOH (osmolarity, 320 mOsm). I-V curves were obtained 
with a holding potential of −90 mV followed by a series of 500-ms 
step pulses that ranged from −110 to +55 mV in 5-mV increments 
(repetition interval, 5 s) before and after 5-min incubation with 
ExTxA (100 nM, 1 M) or MoTxA (10 nM). Conductance-voltage 
curves were obtained by calculating the conductance (G) at each 
voltage (V) using the equation G = I/(V − Vrev), where Vrev is the 
reversal potential and was fitted with a Boltzmann equation. Volt-
age dependence of steady-state fast inactivation was tested using a 
10-ms pulse of −20 mV immediately after the 500-ms step above to 
assess the available noninactivated channels. For statistical compar-
ison on GV and steady-state inactivation curves, a two-tailed paired 
t test was used.
Concentration-response curves were acquired using a holding 
potential of −90 mV and a 50-ms pulse to −20 mV every 20 s (0.05 Hz). 
ExTxA, MoTxA, and PA1b were diluted in ECS with 0.1% BSA. Each 
peptide concentration was incubated for 5 min, and sustained 
current (40 ms from peak current) was normalized to peak current. 
For determination of the off-rate, ExTxA (1 M) was incubated for 
200 s before stepwise washout with ECS every 200 s for 30 min. 
Currents were elicited using a holding potential of −90 mV and a 
50-ms pulse to −20 mV every 20 s (0.05 Hz).
Data analysis
Data were plotted and analyzed using GraphPad Prism version 
8.2.0. Concentration-response curves were fitted to a four-parameter 
Hill equation with variable Hill coefficient. Statistical significance 
was defined as P < 0.05 using tests as indicated. Data are presented 
as means ± SEM.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/38/eabb8828/DC1
View/request a protocol for this paper from Bio-protocol.
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